Keene Brandon A.'s Form 4 filing
Strata Critical Medical, Inc. (SRTA) · filed Sep 14, 2022
- Accession no.
- 0001779128-22-000093
- Filed
- Sep 14, 2022
- Trade date
- Sep 12-14, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $239.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Keene Brandon A.CIK 0001859733 | Officer (Chief Innovation Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2022 | Class A common stock, $0.0001 par value per share | SSaleDisposed | −10,000 | $5.00 | −$50,000 | 388,975 | Direct | |
| Sep 13, 2022 | Class A common stock, $0.0001 par value per share | SSaleDisposed | −5,000 | $4.82 | −$24,100 | 383,975 | Direct | |
| Sep 14, 2022 | Class A common stock, $0.0001 par value per share | SSaleDisposed | −35,000 | $4.72 | −$165,200 | 348,975 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.